Cargando…
Serum microRNA profiling to distinguish papillary thyroid cancer from benign thyroid masses
OBJECTIVES: Papillary thyroid cancer (PTC) is increasing in incidence. Fine needle aspiration is the gold standard for diagnosis, but results can be indeterminate. Identifying tissue and serum biomarkers, like microRNA, is therefore desirable. We sought to identify miRNA that is differentially expre...
Autores principales: | Graham, M. Elise R., Hart, Robert D., Douglas, Susan, Makki, Fawaz M., Pinto, Devanand, Butler, Angela L., Bullock, Martin, Rigby, Matthew H., Trites, Jonathan R. B., Taylor, S. Mark, Singh, Rama |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4560924/ https://www.ncbi.nlm.nih.gov/pubmed/26341226 http://dx.doi.org/10.1186/s40463-015-0083-5 |
Ejemplares similares
-
Serum biomarkers of papillary thyroid cancer
por: Makki, Fawaz M, et al.
Publicado: (2013) -
Differential expression of transforming growth factor-beta in benign vs. papillary thyroid cancer nodules; a potential diagnostic tool?
por: Brace, Matthew D, et al.
Publicado: (2014) -
Papillary thyroid cancer recurrence 43 Years following Total Thyroidectomy and radioactive iodine ablation: a case report
por: Amoako-Tuffour, Yaw, et al.
Publicado: (2017) -
Tumor-to-tumor metastases: papillary thyroid carcinoma into a clear cell renal cell carcinoma
por: Song, Jin Soo Andy, et al.
Publicado: (2017) -
Altered expression of DLG1-AS1 distinguished papillary thyroid carcinoma from benign thyroid nodules
por: He, Tao, et al.
Publicado: (2019)